To me, the only clue is that this is a slow trading day, and few institutional investors are around today - there may also be end-of-month window dressing going on. I wouldn't think this pronounced of a move higher could be confirmed until follow through on high volume/high block trades on Tuesday. My guess is is eases up until close and - all things being equal, geo-politically speaking, over the weekend - a bit of profit taking Tuesday.
If it moved up, it didn't last long. Lows of the day here. Not a good sign...those guys said it was oversold last night and how it reminded them of BBY and other buying opportunities, but this isn't trading well. MS downgrade made sense. Maybe in low $60's it's worth a rebound.
What disguise? I own puts. There was a discussion on Fast Money that focused on this potential dynamic. Why the ad hominem attacks? I am skeptic willing to take a loss if I'm wrong.
simply owing to the idea that many institutions will have to raise money for Alibaba, but remain in balance with regard to overall Chinese exposure...I'm sure they meant the BIDU, YOKU, DANG's of the world, but it can't be good for the whole group to be pressured as a backdrop. Likely this would come into play starting when the adults are back on Tuesday...Labor Day is a bank holiday here in the U.S. Monday.
Labor Day is Monday here in the U.S. - I think a lot of the JRJC bulls may not be aware of that as they aren't here in the states. Do your research. Also, maybe they only pre-released last Q...I didn't see that every Q when I went back over the headlines...could be they only pre-release when they have significant trading gains?
I was under the impression that most of their revenue growth (about 2/3 of last Q's total revenues) has come from their metals trading gains...in other words, one-time gains...and that is why there had been little if any multiple expansion before the CITIC partnership news. So, even if they have great rev's, and y/y and q/q growth...if it's only based on trading gains they won't get much credit for that, right?
She and Cramer were literally laughing at the idea of buying DDD....as though the market cap here is the funniest inside joke. She did saythey would get into 3D space, but only de novo internally generated, industrial additive manufacturing side. Translation, even an old workhorse like HP knows the retail/consumer space is a money-pit.
Bear - please read HLSS's business description in their 10-K if you have not done so....it's pretty clear how important and even existential Ocwen is to HLSS, in so much as they have never acquired an asset that wasn't from Ocwen's pipeline. Of course, Bill Erbey, HLSS's CEO/Chairman, is the same Chairman and founder as Ocwen. Yet you seem to think the link is some how tenuous?
So, if they get this regulatory overhang out of the way, stabilize things...I have to believe this is a bank looking to be acquired. Any one disagree with that logic?
Every day I check with Fdelity - they usually have any where from 50K to 500K available lately. 1.5%
I just read through the transcript, and (though I am a stock guy, not a biotech guy) I agree with your take.